Skip to main content

Table 2 Sociodemographic characteristics and diseases of plaintiffs requesting medicines from January 2003 to December 2015

From: Institutional strategies as a mechanism to rationalize the negative effects of the judicialization of access to medicine in Brazil

Variablesn = 511
Sex n (%)
 Male292 (57.1)
 Female219 (42.9)
Age (years)
 Mean (SD)a42.8 (24.7)
 Median (IQR)b43.0 (20.0–64.0)
Income (US$)
 Mean (SD)a1409.6 (1101.8)
 Median (IQR)b1036.9 (680.5–1506.5)
Total costs of medications in the lawsuit (US$)
 Mean (SD)a1.483.3 (4.345.7)
 Median (IQR)b406.2 (143.9–1198.6)
Quantity of medications n (%)
 Mean (SD)a2.9 (2.4)
 Median (IQR)b2.0 (1.0–4.0)
Prescription’s origin n (%)
 Prescribed by a SUS clinician77 (28.2)
 Prescribed by a private system clinician196 (71.8)
Diseasesc n (%)
 Certain infectious and parasitic diseases5 (1.0)
 Neoplasms7 (1.4)
 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism4 (0.8)
 Endocrine, nutritional and metabolic diseases71 (13.9)
 Mental and behavioural disorders77 (15.1)
 Diseases of the nervous system84 (16.4)
 Diseases of the eye and adnexa17 (3.3)
 Diseases of the circulatory system109 (21.3)
 Diseases of the respiratory system17 (3.3)
 Diseases of the digestive system27 (5.3)
 Diseases of the musculoskeletal system and connective tissue28 (5.5)
 Diseases of the genitourinary system139 (27.2)
  1. aStandard deviation; bInterquartile range; cDiseases were classified according to the chapters of International Statistical Classification of Diseases and Related Health Problems (ICD)